ARTICLES

masimo rad 67
產品與供應商最新動態

FDA Clears Masimo Rad-67 Pulse CO-Oximeter

Masimo announced FDA clearance of the Rad-67™ Pulse CO-Oximeter® with Spot-check Next Generation SpHb® monitoring technology and the rainbow® DCI®-mini Reusable Sensor. Rad-67 offers rainbow® noninvasive hemoglobin measurement (SpHb) and Measure-through Motion and Low Perfusion™ SET® pulse oximetry in a compact, portable spot-check monitoring device. When used with the rainbow® DCI-mini sensor, Rad-67 provides spot-check monitoring […]

產品與供應商最新動態

ResMed Launches Next-generation ReSupply Solution

Brand-agnostic solution helps HMEs provide timely PAP replacement supplies to sleep apnea patients, increases long-term adherence and improves satisfaction ResMed today launched its automated ResMed ReSupply solution for all U.S. home medical equipment (HME) providers to increase sleep apnea patients’ long-term therapy adherence and improve patient satisfaction. Patients enrolled in […]

masimo logo
產品與供應商最新動態

St. Luke’s Achieves Compelling Results After Implementing Masimo Supplemental Remote Monitoring Solution

St. Luke’s University Health Network (St. Luke’s) and Masimo announced that St. Luke’s, a regional network of 10 hospitals and 320 affiliated sites providing service to 10 counties in eastern Pennsylvania, is expanding their use of a variety of Masimo technologies following impressive outcome results at a pilot site. Four years ago, seeking […]

jazz pharma 標誌
Sleep Pharmaceuticals

Jazz Pharmaceuticals 宣布 FDA 核准 Sunosi 用於治療 EDS 及 OSA

Sunosi is the first and only dual-acting dopamine and norepinephrine reuptake inhibitor approved by the FDA to improve wakefulness in adults living with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea  Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) approved Sunosi™ (solriamfetol) to improve wakefulness in adult patients […]